Blue Biofuels (BIOF) Cash & Equivalents (2012 - 2025)

Blue Biofuels (BIOF) has 14 years of Cash & Equivalents data on file, last reported at $65200.0 in Q4 2025.

• On a quarterly basis, Cash & Equivalents rose 33.61% year-over-year to $65200.0 in Q4 2025; TTM through Dec 2025 was $65200.0, a 33.61% increase from a year earlier, with the FY2025 full-year figure at $65200.0, up 33.61% from the prior year.
• Cash & Equivalents for Q4 2025 stood at $65200.0, down from $95194.0 in the prior quarter.
• Over the last five years, Cash & Equivalents for BIOF reached as high as $2.4 million in Q1 2021 and fell as low as $7583.0 in Q1 2025.
• Historically, Cash & Equivalents has averaged $497508.9 across 5 years, with a median of $156244.5 in 2023.
• Across the five-year window, Cash & Equivalents jumped 561.2% in 2024 and plunged 98.03% in 2025, its largest moves.
• Year by year, Cash & Equivalents stood at $1.2 million in 2021, then slumped by 81.81% to $211901.0 in 2022, then slumped by 80.65% to $41008.0 in 2023, then increased by 18.99% to $48797.0 in 2024, then surged by 33.61% to $65200.0 in 2025.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $65200.0 in Q4 2025, $95194.0 in Q3 2025, and $8026.0 in Q2 2025.